Thierry Guillaudeux - Net Worth and Insider Trading
Thierry Guillaudeux Net Worth
The estimated net worth of Thierry Guillaudeux is at least $15,898 dollars as of 2024-11-05. Thierry Guillaudeux is the Chief Scientific Officer of Kineta Inc and owns about 21,696 shares of Kineta Inc (KANT) stock worth over $15,898. Details can be seen in Thierry Guillaudeux's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thierry Guillaudeux has not made any transactions after 2023-09-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Thierry Guillaudeux
Thierry Guillaudeux Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thierry Guillaudeux owns 2 companies in total, including Yumanity Therapeutics Inc (YMTX) , and Kineta Inc (KANT) .
Click here to see the complete history of Thierry Guillaudeux’s form 4 insider trades.
Insider Ownership Summary of Thierry Guillaudeux
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| YMTX | Yumanity Therapeutics Inc | 2022-12-16 | Chief Scientific Officer |
| KANT | Kineta Inc | 2023-09-14 | Chief Scientific Officer |
Thierry Guillaudeux Latest Holdings Summary
Thierry Guillaudeux currently owns a total of 1 stock. Thierry Guillaudeux owns 21,696 shares of Kineta Inc (KANT) as of September 14, 2023, with a value of $15,898.
Latest Holdings of Thierry Guillaudeux
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KANT | Kineta Inc | 2023-09-14 | 21,696 | 0.73 | 15,898 |
Holding Weightings of Thierry Guillaudeux
Thierry Guillaudeux Form 4 Trading Tracker
According to the SEC Form 4 filings, Thierry Guillaudeux has made a total of 1 transactions in Kineta Inc (KANT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Kineta Inc is the acquisition of 10,000 shares on September 14, 2023, which cost Thierry Guillaudeux around $20,000.
Insider Trading History of Thierry Guillaudeux
- 1
Thierry Guillaudeux Trading Performance
GuruFocus tracks the stock performance after each of Thierry Guillaudeux's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thierry Guillaudeux is 96.62%. GuruFocus also compares Thierry Guillaudeux's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thierry Guillaudeux within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Thierry Guillaudeux's insider trading performs compared to the benchmark.
Performance of Thierry Guillaudeux
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 74.88 | | | | | |
| Relative Return to S&P 500(%) | 78.82 | | | | | |
Thierry Guillaudeux Ownership Network
Ownership Network List of Thierry Guillaudeux
Ownership Network Relation of Thierry Guillaudeux
Thierry Guillaudeux Owned Company Details
What does Yumanity Therapeutics Inc do?
Who are the key executives at Yumanity Therapeutics Inc?
Thierry Guillaudeux is the Chief Scientific Officer of Yumanity Therapeutics Inc. Other key executives at Yumanity Therapeutics Inc include director & Chief Executive Officer Shawn Iadonato , Chief Financial Officer Keith Baker , and General Counsel Pauline Kenny .
Yumanity Therapeutics Inc (YMTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Yumanity Therapeutics Inc (YMTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Yumanity Therapeutics Inc (YMTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Yumanity Therapeutics Inc (YMTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Yumanity Therapeutics Inc Insider Transactions
Thierry Guillaudeux Mailing Address
Above is the net worth, insider trading, and ownership report for Thierry Guillaudeux. You might contact Thierry Guillaudeux via mailing address: C/o Kineta, Inc., 219 Terry Ave. N., Suite 300, Seattle Wa 98109.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
